- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/04 - Ortho-condensed systems
Patent holdings for IPC class C07D 487/04
Total number of patents in this class: 22200
10-year publication summary
|
1449
|
1484
|
1577
|
1651
|
1781
|
1662
|
1754
|
1925
|
1655
|
762
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4892 |
517 |
| F. Hoffmann-La Roche AG | 7926 |
375 |
| Novartis AG | 10904 |
326 |
| Janssen Pharmaceutica N.V. | 3423 |
309 |
| Hoffmann-La Roche Inc. | 3379 |
290 |
| Gilead Sciences, Inc. | 2028 |
286 |
| Merck Sharp & Dohme LLC | 3741 |
282 |
| Merck Patent GmbH | 5850 |
279 |
| Incyte Corporation | 1011 |
258 |
| Boehringer Ingelheim International GmbH | 4704 |
233 |
| Genentech, Inc. | 3961 |
206 |
| Dana-Farber Cancer Institute, Inc. | 2553 |
197 |
| Pfizer Inc. | 3367 |
185 |
| Takeda Pharmaceutical Company Limited | 2704 |
183 |
| AstraZeneca AB | 2928 |
162 |
| Incyte Holdings Corporation | 653 |
151 |
| Abbvie Inc. | 1802 |
129 |
| The Regents of the University of California | 19812 |
117 |
| Amgen Inc. | 4047 |
116 |
| LG Chem, Ltd. | 17561 |
114 |
| Other owners | 17485 |